Skip to main content
. 2022 Nov 1;379:e071380. doi: 10.1136/bmj-2022-071380

Fig 5.

Fig 5

Study flow diagram of patients starting sulfonylureas or sodium-glucose co-transporter-2 (SGLT-2) inhibitors in UK Clinical Practice Research Datalink between 2013 and 2019. COPD=chronic obstructive pulmonary disease